Clinical Trial Update: Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial from the Children's Oncology Group assesses Rituximab, Rasburicase, and combination chemotherapy in children with newly diagnosed advanced B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Immunoblastic Large Cell Lymphoma

Drugs mentioned

• ELITEK (rasburicase)
• Rituximab (rituximab)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-22